Get the Stockscreener App
40.90
0.99%
-0.41
After Hours:
40.85
-0.05
-0.12%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $40.90, with a volume of 492.18K.
It is down -0.99% in the last 24 hours and up +10.54% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
See More
Previous Close:
$41.31
Open:
$41.7
24h Volume:
492.18K
Relative Volume:
0.49
Market Cap:
$2.17B
Revenue:
$238.11M
Net Income/Loss:
$-31.45M
P/E Ratio:
-64.57
EPS:
-0.6334
Net Cash Flow:
$7.66M
1W Performance:
-0.22%
1M Performance:
+10.54%
6M Performance:
+52.21%
1Y Performance:
+273.86%
1-Day Range:
$40.74
$41.72
1-Week Range:
$40.62
$44.22
52-Week Range:
$9.215
$45.83
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
40.90 | 2.20B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Wells Fargo | Overweight |
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Precision Trading with Axogen Inc. (AXGN) Risk Zones - Stock Traders Daily
Which Is a Better Investment, Axogen, Inc. or Omnicell, Inc. Stock? - AAII
Stephens Investment Management Group LLC Acquires New Stake in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) price target increased by 16.82% to 51.71 - MSN
Bessemer Group Inc. Sells 345,347 Shares of AxoGen, Inc. $AXGN - MarketBeat
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam - Yahoo Finance
AxoGen, Inc. $AXGN Shares Purchased by Vanguard Group Inc. - MarketBeat
HighMark Wealth Management LLC Acquires 158,855 Shares of AxoGen, Inc. $AXGN - MarketBeat
Axogen director sells shares after option exercise | AXGN Insider Trading - Stock Titan
Technical Reactions to AXGN Trends in Macro Strategies - Stock Traders Daily
Insider Sell Alert: Jens Kemp Sells 4,000 Shares of Axogen Inc (AXGN) - GuruFocus
Axogen CMO Jens Kemp sells $173,761 in company stock By Investing.com - Investing.com Nigeria
Axogen CFO Lindsey Hartley sells $45,897 in AXGN stock By Investing.com - Investing.com Nigeria
Axogen CFO Lindsey Hartley sells $45,897 in AXGN stock - Investing.com UK
[144] Axogen, Inc. SEC Filing - Stock Titan
Axogen (AXGN) director exercises options and sells 11,050 common shares - Stock Titan
[Form 4] Axogen, Inc. Insider Trading Activity - Stock Titan
Axogen (AXGN) CMO sells 4,000 shares around $43 per share - Stock Titan
Axogen (NASDAQ: AXGN) CFO nets shares after option exercises and sales - Stock Titan
Axogen (AXGN) Sales VP sells 3,878 shares, retains 92,416 - Stock Titan
Axogen (NASDAQ: AXGN) VP Quackenbush discloses initial equity holdings - Stock Titan
AxoGen, Inc. (AXGN) Stock Analysis: 17% Upside Potential Amid Robust Revenue Growth - DirectorsTalk Interviews
Axogen Director Sold Shares Worth Over $720K - TradingView
AXGN (NASDAQ) Form 144 lists 3,878 shares via Morgan Stanley broker - Stock Titan
First Light, Mathew Arens report 3.62M Axogen holdings (AXGN) - Stock Titan
How many employees work at AxoGen? - Revelio Labs
Number of shareholders of Axogen, Inc. – NASDAQ:AXGN - TradingView
Axogen outlines at least $270M 2026 revenue on at least 20% growth amid Avance biologic channel transition - MSN
Canaccord Genuity Sticks to Its Buy Rating for AxoGen (AXGN) - The Globe and Mail
Axogen (AXGN) Is Up 10.3% After Raising 2026 Revenue Outlook Despite Wider Q1 Loss – Has The Bull Case Changed? - simplywall.st
Axogen (AXGN) Q1 2025 Earnings Transcript - AOL.com
AxoGen (NASDAQ:AXGN) Cut to "Hold" at Wall Street Zen - MarketBeat
Axogen, Inc. (NASDAQ:AXGN) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Axogen (AXGN) Q1 2026 Deep Dive: $0.07 EPS, Revenue Up 27% - AlphaStreet
Nerve Repair And Regenerative Market Set to Boom Rapidly, - openPR.com
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference - The Manila Times
Axogen, Inc. (NASDAQ:AXGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$50.78 - simplywall.st
AxoGen Reports Third Quarter 2025 Financial Results and Growth - HarianBasis.co
AXGN SEC FilingsAxogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
AXGN Maintained by Canaccord Genuity -- Price Target Raised to $50 - GuruFocus
Vanguard reports 2.66M Axogen stake (NASDAQ: AXGN) - Stock Titan
[ARS] Axogen, Inc. SEC Filing - Stock Titan
FDA win and 20% growth frame Axogen (NASDAQ: AXGN) 2026 pay vote - Stock Titan
AXGN Maintained by Citizens -- Price Target Raised to $50.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):